Rani Therapeutics Holdings Inc - Class A — Cash Flow (NASDAQ:RANI)

Financials

Cash from operating activities 32.2 M46.5 M51.2 M35.5 M 27.66 M Cash from investing activities 506 K72.44 M29.86 M19.81 M 26.46 M Cash from financing activities 77.15 M29 M233 K13.59 M 10.17 M Free cash flow 31.69 M44.88 M49.97 M35.23 M 27.54 M

新闻

라니 테라퓨틱스, 알리레자 자바디 CTO로 승진

Rani Therapeutics promotes Alireza Javadi to chief technical officer

Rani Therapeutics begins phase 1 trial of oral obesity treatment

Rani Therapeutics, 의결권 축소 및 세금 계약 종료

Rani Therapeutics amends charter, reduces Class B voting power and ends tax agreement

Rani, 쥬가이 제약과 10억 8,500만 달러 규모 협력

Rani Therapeutics announces $1.085 billion Chugai collaboration

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.09%

Monday’s Insider Moves: Top Buys and Sells in US Stocks on October 27

Rani Therapeutics 이사, 16억 원 상당 주식 매입

Rani Therapeutics director Imran Mir a buys $1.26 million in stock

Rani Therapeutics, 이사 임명 및 사모 자금 조달 마감